姓名 | 職稱 | 持有股份 | 代表法人 |
---|---|---|---|
Wang,Shu-Wen | Chairman | 0.01% | |
Hong,Rui-Ting | Director | 1.54% | |
BEI YU LTD. | Director | 0.00% | |
XIN XIN Ltd. | Director | 0.00% | |
Chen,Kun-Tang | Director | 0.16% | |
Su,Bai-Huang | Director | 0.00% | |
Xie,Guo-Song | Director | 9.40% | YI YUAN INVESTMENT CO., LTD. |
Qu,Jian-Zhong | Director | 0.00% | |
You,Zheng-Ping | Independent Director | 0.00% | |
Liu,Nai-Ming | Independent Director | 0.00% | |
Shi,Tian-Wei | Independent Director | 0.00% | |
Chen,Xiao-Kai | Independent Director | 0.00% | |
Lai,Qiu-Jun | Independent Director | 0.00% |
項目 | 2025 | 2024 | 2023 |
---|---|---|---|
Operating income | 9,374,606 | 36,828,499 | 30,790,462 |
Operating cost | 6,543,209 | 25,459,513 | 21,111,381 |
Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
Operating gross profit (loss) | 2,831,397 | 11,368,986 | 9,679,081 |
Unrealized profit (loss) on sales of goods | - | - | - |
Realized profit (loss) on sales of goods | - | - | - |
Operating gross profit (loss), net | 2,831,397 | 11,368,986 | 9,679,081 |
Operating expenses | 856,039 | 3,613,561 | 3,130,231 |
Other gain (loss), net | - | - | - |
Operating profit (loss) | 1,975,358 | 7,755,425 | 6,548,850 |
Non-operating income and expenses | 111,730 | 595,503 | 126,748 |
Net profit (loss) before tax | 2,087,088 | 8,350,928 | 6,675,598 |
Income tax expense (benefits) | 407,699 | 1,710,076 | 1,499,131 |
Net profit (loss) of ongoing business for the current period | 1,679,389 | 6,640,852 | 5,176,467 |
Profit (loss) of closed units | - | - | - |
Profit (loss) of non-jointly controlled equity before merger | - | - | - |
Net profit (loss) for the current period | 1,679,389 | 6,640,852 | 5,176,467 |
Other comprehensive profit (loss), net | 76,129 | 313,928 | 16,388 |
Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
Total comprehensive profit and loss for the current period | 1,755,518 | 6,954,780 | 5,192,855 |
Net profit (loss) attributable to owners of parent company | 1,679,389 | 6,640,852 | 5,176,467 |
Net profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
Net profit (loss) attributable to non-controlling interests | - | - | - |
Comprehensive profit (loss) attributable to owners of parent company | 1,755,518 | 6,954,780 | 5,192,855 |
Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
Comprehensive profit (loss) attributable to non-controlling interests | - | - | - |
Basic earnings per share (yuan) | 6 | 24 | 18 |
項目 | 2025 | 2024 | 2023 |
---|---|---|---|
Net cash inflow (outflow) from operating activities | 1,328,857 | 4,720,354 | 4,664,144 |
Net cash inflows (outflows) from investing activities | -1,647,395 | -791,797 | -1,835,895 |
Net cash inflow (outflow) from financing activities | -291,830 | -3,109,407 | -6,051,743 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | 24,392 | -14,704 | 14,956 |
Increase (decrease) in cash and cash equivalents in the current period | -585,976 | 804,446 | -3,208,538 |
Beginning balance of cash and cash equivalents | 3,618,179 | 2,813,733 | 6,022,271 |
Ending balance of cash and cash equivalents | 3,032,203 | 3,618,179 | 2,813,733 |
項目 | 2025 | 2024 | 2023 |
---|---|---|---|
Current asset | 23,007,234 | 21,508,022 | 17,398,018 |
Non-current asset | 14,338,355 | 14,357,098 | 14,434,717 |
Total asset | 37,345,589 | 35,865,120 | 31,832,735 |
Current liability | 11,154,379 | 6,766,856 | 6,080,958 |
Non-current liability | 178,272 | 176,603 | 81,196 |
Total liability | 11,332,651 | 6,943,459 | 6,162,154 |
share capital | 2,743,671 | 2,743,671 | 2,743,671 |
Equity - secruity token | - | - | - |
capital reserve | 3,769,803 | 3,769,803 | 3,769,547 |
retained earning | 19,096,065 | 22,080,917 | 19,117,834 |
Other equity | 403,399 | 327,270 | 39,529 |
Treasury stock | - | - | - |
Total equity attributable to owners of parent company | 26,012,938 | 28,921,661 | 25,670,581 |
Equity attributable to former owner of business combination under common control | - | - | - |
Equity attributable to non-controlling interest before business merger under common control | - | - | - |
Non-controlling interests | - | - | - |
Total Equity | 26,012,938 | 28,921,661 | 25,670,581 |
Share capital awaiting retirement (unit: share) | - | - | - |
Issued shares of advance equity (unit: shares) | 0 | 0 | 0 |
Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 | 0 | 0 |
Net asset value per share | 94 | 105 | 93 |
標案名稱 | 機關名稱 | 決標日期 | 決標金額 | 是否得標 |
---|---|---|---|---|
109年隔離衣緊急採購案 | 衛生福利部疾病管制署 | 109/03/06 | 12540000.0 | 是 |
日期 | 違反法規法條 | 罰鍰金額 |
---|---|---|
2024/05/07 | Paragraph 1, Article 6 of the Occupational Safety and Health Act; Paragraph 1, Article 6 of the Occupational Safety and Health Act; Paragraph 1, Article 6 of the Occupational Safety and Health Act | |
2020/11/09 | Paragraph 1, Article 6 of the Occupational Safety and Health Act | |
2018/09/10 | Article 24 of the Labor Standards Act | |
2017/10/25 | Paragraph 1, Article 6 of the Occupational Safety and Health Act |